Last week we had the opportunity to present and represent Acarix and our CADScor(R)system at the Emerging Medtech Summit in the US. The meeting was attended by more than 400 engaged participants coming from both from the industry and market access communities as well as from the investor side. One highlight was the opportunity to present the CADScor(R) and Acarix for all attendees, presenting the unique innovation and improvement it offers. In addition we gained traction and interest from several stakeholders being able to support and help develop the early work started on our journey towards the US market.
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.